CraigMoskMD Profile Banner
Craig Moskowitz, MD Profile
Craig Moskowitz, MD

@CraigMoskMD

Followers
2K
Following
74
Media
13
Statuses
170

Physician in Chief, @SylvesterCancer @UMiamihealth #Lymphoma #Cancerdoc #Golfer #hodgkin

Miami, FL
Joined June 2018
Don't wanna be here? Send us removal request.
@CraigMoskMD
Craig Moskowitz, MD
1 year
Congratulations to Steve Nimer for receiving the ash mentor award; he has mentored me for the past 30 years!
1
1
18
@CraigMoskMD
Craig Moskowitz, MD
1 year
Amazing presentation by Juan Alderuccio at ASH clearly showing that Lonca T and rituxan as a new option for poor risk first relapse Follicular lymphomas
0
1
17
@CraigMoskMD
Craig Moskowitz, MD
1 year
Fascinating data at ISHL describing 3 unique HL subtypes which will have implications on future precision med based treatment approaches
1
1
11
@CraigMoskMD
Craig Moskowitz, MD
2 years
Great meeting in Naples post graduate lymphoma meeting 8 with thoughtful presentations and special thanks to dr zinzani for inviting me to participate
0
1
9
@CraigMoskMD
Craig Moskowitz, MD
2 years
Great day for our Sylvester Over 6500 participants walking or running or riding at the dolphins challenge cancer event where all donations go directly for cancer research and I am so proud to be part of our faculty and our team cure lymphoma now!
0
1
23
@CraigMoskMD
Craig Moskowitz, MD
2 years
Best social function at ASH23 - Miami nights only 3 hours away!
1
0
16
@CraigMoskMD
Craig Moskowitz, MD
2 years
Please take asco abim survey it is critical, once again why does an oncology sub specialist need to know general med oncology? Seeing only Lymphoma pts for 30 years should exclude me from all questions other than Lymphoma!
2
4
31
@CraigMoskMD
Craig Moskowitz, MD
2 years
It may be premature to state nivo avd is the new standard in advanced stage HL Let’s see the data with a medium follow up of 2 years, however the data thus far is amazing!
1
0
24
@CraigMoskMD
Craig Moskowitz, MD
3 years
Ethan Stone Moskowitz born on 4/18 three grandchildren in 14 months!
31
1
130
@drmelissalopez
Melissa Lopez-Pentecost, PhD, RDN
3 years
Presenting the Lifestyle Intervention of Food and Exercise in Lymphoma patients (LIFE-L) protocol at #AACR2023. This pilot randomized trial seeks to improve treatment adherence and completion through a Mediterranean diet and exercise intervention🥙💪
0
5
22
@CraigMoskMD
Craig Moskowitz, MD
3 years
Great 7th annual post graduate lymphoma conference in rome and many thanks to Dr Zinzani who organized the meeting
0
0
18
@CraigMoskMD
Craig Moskowitz, MD
3 years
What at day for the Sylvester comprehensive cancer center family with 5600 folks participating in the dolphins challenge cancer event and I am proud to be a member!
2
1
26
@CraigMoskMD
Craig Moskowitz, MD
3 years
Great holiday lunch with the lymphoma research team!
1
0
67
@CraigMoskMD
Craig Moskowitz, MD
3 years
Amazing sylvester cancer center retreat yesterday everyone is all juiced up for a great 2023!
2
1
37
@CraigMoskMD
Craig Moskowitz, MD
3 years
Congrats to our son josh and new daughter dani on getting married today and may their life together be filled with love and happiness and many more grandchildren for robin and I!
15
0
87
@CraigMoskMD
Craig Moskowitz, MD
3 years
Congratulations to my friend steve Horwitz for receiving the LRF distinguished leadership award for his unwavering dedication in improving outcome for patients with T cell lymphoma
1
2
33
@CraigMoskMD
Craig Moskowitz, MD
3 years
The time is finally here! Breaking ground on the transformational cancer research bldg @SylvesterCancer
3
10
114
@innovateshealth
Desert
4 years
This morning on the coral gables campus @SylvesterCancer director @DrSDNimer and your favorite doctors came together to discuss our progress in clinical research and patient care! #SylvesterCancer Network Clinical Faculty Retreat
0
7
38
@CraigMoskMD
Craig Moskowitz, MD
4 years
Masters starting today for golfers does not get any better
1
0
9
@CraigMoskMD
Craig Moskowitz, MD
4 years
I agree it is great to have more options for diffuse large B cell lymphoma but a word of caution axicel pts lacked tumor bulk or significant disease burden and it is critical that these pts receive traditional salvage chemotherapy prior to any cellular therapy
5
13
116